Ed Dowd On Pfizer Increasing Their Revenue to $90B After Covid-19 | Ep. 244 | Part 1
PBD Podcast
00:00
Post-Pandemic Health Narratives
This chapter examines the revenue shifts in a major pharmaceutical company post-COVID-19 and discusses societal reactions to health incidents highlighted in the media. It explores the rise in mortality rates among young Americans and the complexities of gathering accurate health data amidst public skepticism. The conversation delves into vaccination trends, personal choices influenced by societal pressures, and the broader implications of health narratives surrounding the pandemic.
Transcript
Play full episode
